Skip to main content
. 2021 Jan 5;4(1):96–100. doi: 10.1021/acsptsci.0c00156

Table 2. Concentration of Intracellular Gemcitabine in Suspension K562 Cells Using SCMS and LCMS.

treatment concentration (μM) SCMS (μM)a LCMS (μM)
0.1 10.9 ± 7.1 17.4 ± 5.0
1.0 17.9 ± 11.9 18.1 ± 5.8
10 37.3 ± 26.1 28.0 ± 12.6
a

n > 20 cells for each treatment condition.